Ciprofloxacin Resistance in Escherichia Coli Strains Isolated from Urinary Tract Infections
Abstract
Background: The purpose of this investigation was to show how resistant E. Coli is towards the fluoroquinolone treatment Ciprofloxacin. There were 140 specimens in total. It is widely recognized that infections of the urinary tract are a prevalent condition in women and men and different ages. The bacteria that cause E. Coli becomes more resistant as a result of increased consumption of antibiotics, which means this symptom is dangerous on a worldwide scale. Methods: Within Al-Hindya Teaching Hospital, specimens of urine involving individuals of different age have been employed to isolate the E. Coli germs. The required separation procedures have been conducted, comprising genetic sequencing of the bacterial strain carbon monoxide gene, microscopical examination, plus biochemical examinations. The resulting isolates were subjected to the procedure called polymerase chain reaction (PCR), and their resistance to antibiotics was assessed by putting discs containing antibiotics on the Mueller_ Hinton agar. Results: Compared to males, girls had a greater rate of E. Coli disease. The bacteria that underwent responsiveness testing employed ciprofloxacin, and that microbes rate of resistance to this antibiotic was somewhat higher than its level of sensitivity. Investigating the growing resistance of Ur pathogenic E. Coli bacterium to the antibiotic ciprofloxacin is the goal objective this investigation.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.